Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 1 56Phase 1/2 20Phase 3 15Phase NA 10Phase 4 4Phase EARLY_PHASE1 2Phase 2/3 2

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Tumor-Agnostic 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Carcinoma, Renal Cell 3Thyroid Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Endometrial Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Breast Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × pazopanib × Clear all
NCT02555748 2026-03-31

SUP-R

Institut Claudius Regaud

Phase 4 Completed
47 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05949424 2023-11-29

OPTI-DOSE

University Medical Center Groningen

Phase 4 Unknown
30 enrolled
BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT01521715 2017-08-23

FLIPPER

iOMEDICO AG

Phase 4 Completed
44 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT01205230 2012-05-22

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK

GlaxoSmithKline

Phase 4 Completed
34 enrolled 17 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡